Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BTICVE:PASNYSE:PMCVE:SVS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTIBritish American Tobacco$45.24+1.4%$41.96$30.01▼$45.29$93.51B0.324.96 million shs4.32 million shsPASPascal BiosciencesC$0.02-25.0%C$0.02C$0.02▼C$0.10C$984K1.5152,289 shs4,000 shsPMPhilip Morris International$178.23+1.7%$162.60$98.93▼$178.70$277.36B0.55.61 million shs6.16 million shsSVSSolarvest BioEnergyC$0.03C$0.02C$0.01▼C$0.14C$1.52M1.577,594 shs3,159 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTIBritish American Tobacco0.00%+6.16%+6.62%+19.69%+44.23%PASPascal Biosciences0.00%0.00%0.00%0.00%0.00%PMPhilip Morris International0.00%+4.61%+4.68%+15.44%+76.34%SVSSolarvest BioEnergy0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBTIBritish American Tobacco2.6051 of 5 stars1.45.03.30.03.10.01.9PASPascal BiosciencesN/AN/AN/AN/AN/AN/AN/AN/APMPhilip Morris International3.7891 of 5 stars2.53.03.30.03.02.51.3SVSSolarvest BioEnergyN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBTIBritish American Tobacco 2.75Moderate Buy$33.00-27.05% DownsidePASPascal Biosciences 0.00N/AN/AN/APMPhilip Morris International 2.91Moderate Buy$169.20-5.06% DownsideSVSSolarvest BioEnergy 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest BTI, PM, SVS, and PAS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/22/2025PMPhilip Morris InternationalNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy5/22/2025PMPhilip Morris InternationalNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeModerate Buy$195.005/2/2025PMPhilip Morris InternationalBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$175.00 ➝ $205.004/30/2025BTIBritish American TobaccoBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy4/25/2025PMPhilip Morris InternationalUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeSell ➝ Neutral$130.00 ➝ $170.004/24/2025PMPhilip Morris InternationalMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$156.00 ➝ $182.004/24/2025PMPhilip Morris InternationalStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$168.00 ➝ $186.004/16/2025PMPhilip Morris InternationalCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$163.00 ➝ $180.004/10/2025PMPhilip Morris InternationalStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$160.00 ➝ $168.003/14/2025PMPhilip Morris InternationalArgusSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy2/26/2025PMPhilip Morris InternationalBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$145.00 ➝ $175.00(Data available from 5/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBTIBritish American Tobacco$25.87B3.62$7.58 per share5.97$30.81 per share1.47PASPascal BiosciencesN/AN/AC$0.00 per share55.00C($0.02) per shareN/APMPhilip Morris International$38.39B7.23$9.12 per share19.54($6.35) per share-28.07SVSSolarvest BioEnergyC$740.002,052.70C$0.00 per share55.00C($0.10) per share-0.25Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBTIBritish American Tobacco$3.92B$4.879.299.07N/AN/AN/AN/A7/31/2025 (Estimated)PASPascal BiosciencesN/A-C$0.01N/A∞N/AN/AN/A-340.40%N/APMPhilip Morris International$7.06B$4.8539.5222.562.657.89%-120.08%15.76%7/22/2025 (Estimated)SVSSolarvest BioEnergy-C$2.26M-C$0.04N/A∞N/AN/AN/A-143.12%N/ALatest BTI, PM, SVS, and PAS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/23/2025Q1 2025PMPhilip Morris International$1.61$1.69+$0.08$1.72$9.10 billion$9.30 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBTIBritish American Tobacco$2.956.52%+0.40%60.57%N/APASPascal BiosciencesN/AN/AN/AN/AN/APMPhilip Morris International$5.403.03%+2.65%111.34%17 YearsSVSSolarvest BioEnergyN/AN/AN/AN/AN/ALatest BTI, PM, SVS, and PAS DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/6/2025PMPhilip Morris Internationalquarterly$1.353.53%3/20/20253/20/20254/10/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBTIBritish American Tobacco0.650.760.58PASPascal Biosciences882.790.030.17PMPhilip Morris InternationalN/A0.880.47SVSSolarvest BioEnergyN/AN/A0.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBTIBritish American Tobacco16.16%PASPascal BiosciencesN/APMPhilip Morris International78.63%SVSSolarvest BioEnergyN/AInsider OwnershipCompanyInsider OwnershipBTIBritish American Tobacco0.03%PASPascal Biosciences15.43%PMPhilip Morris International0.13%SVSSolarvest BioEnergy15.85%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBTIBritish American Tobacco52,0002.07 billion2.07 billionOptionablePASPascal Biosciences665.59 millionN/ANot OptionablePMPhilip Morris International79,8001.56 billion1.55 billionOptionableSVSSolarvest BioEnergyN/A60.76 millionN/ANot OptionableBTI, PM, SVS, and PAS HeadlinesRecent News About These CompaniesSolarvest order book to surpass RM2bil in FY26May 21, 2025 | thestar.com.mySolarvest optimistic orderbook to surpass RM2bil in FY26May 21, 2025 | thestar.com.myMIDA Facilitates RM142 Mln Energy Partnership Between Solarvest, HSS & Shizen At Osaka ExpoApril 17, 2025 | bernama.comWhile private companies own 23% of Solarvest Holdings Berhad (KLSE:SLVEST), individual investors are its largest shareholders with 32% ownershipApril 16, 2025 | finance.yahoo.comSolarvest order book hits record RM1.4bilMarch 27, 2025 | thestar.com.mySolarvest maintains sunny outlookMarch 27, 2025 | thestar.com.mySolarvest To Be Prime Beneficiary Of Large-scale Solar Contracts - HLIBMarch 27, 2025 | bernama.comSolarvest unit wins RM103mil EPCC contractMarch 27, 2025 | thestar.com.mySolarvest unit secures RM103.08mil EPCC contract for solar PV facility in Pulau PinangMarch 26, 2025 | thestar.com.myUpbeat outlook for Solarvest on LSS5 plan shortlistMarch 21, 2025 | thestar.com.mySolarvest subsidiary signs PPA for 60MWac solar PV facilityMarch 19, 2025 | thestar.com.mySolarvest In Good Position To Capitalise On Malaysia RE Sector Opportunities - Maybank IBMarch 19, 2025 | bernama.comSolarvest bags EPCC deal valued at RM401milMarch 18, 2025 | thestar.com.mySolarvest unit bags RM401mil EPCC works project under LSS5March 17, 2025 | thestar.com.mySolarvest’s prospects brighten with new projectsFebruary 26, 2025 | thestar.com.mySolarvest net profit jumps 35% in 3Q25February 20, 2025 | thestar.com.mySolarvest's net profit jumps 35% to record RM14.4mil in 3QFY25February 20, 2025 | thestar.com.mySolarvest Holdings Berhad's (KLSE:SLVEST) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?February 3, 2025 | finance.yahoo.comSolarvest stake buy in Kee Ming Electrical seen as a good moveJanuary 28, 2025 | thestar.com.mySolarvest to obtain stake in M&E firmJanuary 27, 2025 | thestar.com.myNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesBuybacks and Big-Time Developments: 3 Stocks Making Huge MovesBy Leo Miller | May 19, 2025View Buybacks and Big-Time Developments: 3 Stocks Making Huge MovesApplied Digital's Strategic AI Play Gains MomentumBy Jeffrey Neal Johnson | May 21, 2025View Applied Digital's Strategic AI Play Gains MomentumD-Wave Quantum: Hidden Opportunity or Short Seller's Dream?By Nathan Reiff | May 6, 2025View D-Wave Quantum: Hidden Opportunity or Short Seller's Dream?Texas Instruments: Earnings Beat, Upbeat Guidance Fuel RecoveryBy Jeffrey Neal Johnson | April 27, 2025View Texas Instruments: Earnings Beat, Upbeat Guidance Fuel RecoveryAlphabet Gets JPMorgan’s Vote of Confidence After Google I/OBy Ryan Hasson | May 22, 2025View Alphabet Gets JPMorgan’s Vote of Confidence After Google I/OBTI, PM, SVS, and PAS Company DescriptionsBritish American Tobacco NYSE:BTI$45.24 +0.64 (+1.43%) Closing price 05/23/2025 03:59 PM EasternExtended Trading$45.27 +0.03 (+0.07%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.British American Tobacco p.l.c. engages in the provision of tobacco and nicotine products to consumers worldwide. It also offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company offers its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Camel, Natural American Spirit, Newport, Vogue, Viceroy, Kool, Peter Stuyvesant, Craven A, State Express 555 and Shuang Xi brands. It also distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.Pascal Biosciences CVE:PASC$0.02 -0.01 (-25.00%) As of 12/5/2022Pascal Biosciences Inc., a biotechnology company, engages in the research and development of products for the treatment of cancer, and for the improvement of the immune system. The company's development portfolio includes PAS-403, a mitosis inhibitor that blocks cell division for the treatment of glioblastoma and brain metastases originating from other cancers; and PAS-393, an immune-stimulatory cannabinoid designed to restore the immunogenicity of tumor cells with checkpoint inhibitor therapy for use in cancer treatment. It is also developing a B-cell targeted antibody for acute lymphoblastic leukemia and B cell lymphomas; and cannabinoid therapeutic products for the treatment of COVID-19. The company has an exclusive license agreement with the University of Washington to develop a cannabinoid-based product for the treatment of glioblastoma multiforme and brain metastases; and a collaborative research agreement with SoRSE Technology Corporation to advance PAS-393 into clinical testing. Pascal Biosciences Inc. was incorporated in 2011 and is headquartered in Seattle, Washington.Philip Morris International NYSE:PM$178.23 +3.00 (+1.71%) Closing price 05/23/2025 03:59 PM EasternExtended Trading$178.32 +0.09 (+0.05%) As of 05/23/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products primarily under the IQOS and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness and healthcare products. Philip Morris International Inc. was incorporated in 1987 and is headquartered in Stamford, Connecticut.Solarvest BioEnergy CVE:SVSC$0.02 0.00 (0.00%) As of 09/5/2023Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products. It provides human nutrition products, including omega-3; clean energy production system that enables for continuous hydrogen production; and active ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. Solarvest BioEnergy Inc. has a collaborative research and development agreement with FSD Pharma Inc. to produce cannabidiol (CBD), Cannabigerol (CBG), and tetrahydrocannabinol (THC) programs. The company was incorporated in 2005 and is based in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Trade Desk Silences Critics; Recovery Looks Poised to Continue Alphabet Stock Lags—But Waymo May Be Its Hidden Driver Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain These ETFs Provide Easy Exposure to Growing International Markets Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
